Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle
Aminoglycosides force read through of premature stop codon mutations and introduce new mutation-specific gene-corrective strategies in Duchenne muscular dystrophy. A chronic treatment with gentamicin (32 mg/kg/daily i.p., 8–12 weeks) was performed in exercised mdx mice with the dual aim to clarify t...
Hlavní autoři: | , , , , , , , , , , , , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Elsevier
2008-11-01
|
Edice: | Neurobiology of Disease |
Témata: | |
On-line přístup: | http://www.sciencedirect.com/science/article/pii/S0969996108001575 |